Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
暂无分享,去创建一个
P. Nordbeck | G. Ertl | K. Hu | Dan Liu | B. Lengenfelder | Clara Hammel | S. Frantz | L. Schregelmann
[1] Y. Yoon,et al. Combined effects of ARNI and SGLT2 inhibitors in diabetic patients with heart failure with reduced ejection fraction , 2021, Scientific Reports.
[2] S. Solomon,et al. Management of hypertension in heart failure with preserved ejection fraction: is there a blood pressure goal? , 2021, Current opinion in cardiology.
[3] D. Mann,et al. Improvement of ejection fraction and mortality in ischaemic heart failure , 2020, Heart.
[4] D. Mann,et al. Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel. , 2020, Journal of the American College of Cardiology.
[5] Akshay S. Desai,et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. , 2019, The New England journal of medicine.
[6] Y. Pinto,et al. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction , 2019, Heart.
[7] G. Gulati,et al. Heart Failure With Improved Ejection Fraction: Is it Possible to Escape One's Past? , 2018, JACC. Heart failure.
[8] R. A. Agra Bermejo,et al. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry. , 2018, Cardiology journal.
[9] James E. Tcheng,et al. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials , 2018, Circulation.
[10] A. Dunning,et al. Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block. , 2018, Journal of the American College of Cardiology.
[11] Anne L. Taylor,et al. Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial. , 2017, Journal of cardiac failure.
[12] Akshay S. Desai,et al. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. , 2018, Journal of the American College of Cardiology.
[13] M. de Antonio,et al. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study , 2017, European journal of heart failure.
[14] Roland A Matsouaka,et al. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. , 2017, Journal of the American College of Cardiology.
[15] K. Anstrom,et al. Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial , 2017, JAMA.
[16] M. Guazzi,et al. Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction , 2017, European journal of heart failure.
[17] Patrizio Lancellotti,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.
[18] P. Ponikowski,et al. [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.
[19] Dean Y. Li,et al. Cardiac Recovery During Long-Term Left Ventricular Assist Device Support. , 2016, Journal of the American College of Cardiology.
[20] J. Cohn,et al. Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival Results From the Valsartan Heart Failure Trial , 2016, Circulation. Heart failure.
[21] Patrizio Lancellotti,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[22] M. Cho,et al. Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF , 2015, Heart.
[23] Victor Mor-Avi,et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[24] A. Zwinderman,et al. Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure. , 2014, JACC. Heart failure.
[25] Akshay S. Desai,et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.
[26] Mark Woodward,et al. Risk prediction in patients with heart failure: a systematic review and analysis. , 2014, JACC. Heart failure.
[27] D. Mann,et al. Epidemiology and Natural History of Recovery of Left Ventricular Function in Recent Onset Dilated Cardiomyopathies , 2013, Current Heart Failure Reports.
[28] Bart Bijnens,et al. Clinical implication of mitral annular plane systolic excursion for patients with cardiovascular disease. , 2013, European heart journal cardiovascular Imaging.
[29] J. G. González Juanatey,et al. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry. , 2013, Cardiology journal.
[30] J. Cleland,et al. Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure. , 2012, Journal of cardiac failure.
[31] C. O'connor,et al. Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. , 2012, American heart journal.
[32] Marco Merlo,et al. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. , 2011, Journal of the American College of Cardiology.
[33] M. Cicoira,et al. Progression of Left Ventricular Dysfunction and Remodelling under Optimal Medical Therapy in CHF Patients: Role of Individual Genetic Background , 2011, Cardiology research and practice.
[34] G. Hillis,et al. Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta‐analysis of longitudinal data (MeRGE Heart Failure) , 2009, European journal of heart failure.
[35] Miguel Ventura,et al. Identification of 'super-responders' to cardiac resynchronization therapy: the importance of symptom duration and left ventricular geometry. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[36] N. Lamblin,et al. The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis. , 2007, American heart journal.
[37] Einar Heiberg,et al. The quantitative relationship between longitudinal and radial function in left, right, and total heart pumping in humans. , 2007, American journal of physiology. Heart and circulatory physiology.
[38] B. Sveälv,et al. Ventricular long-axis function is of major importance for long-term survival in patients with heart failure , 2007, Heart.
[39] Peter C Austin,et al. Outcome of heart failure with preserved ejection fraction in a population-based study. , 2006, The New England journal of medicine.
[40] L. Tavazzi,et al. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. , 2000, The American journal of cardiology.
[41] D G Gibson,et al. Normal long axis function , 1999, Heart.